Form 8-K - Current report:
SEC Accession No. 0001485003-22-000004
Filing Date
2022-01-06
Accepted
2022-01-06 08:00:17
Documents
12
Period of Report
2022-01-06
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20220106.htm   iXBRL 8-K 42049
  Complete submission text file 0001485003-22-000004.txt   184201

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20220106.xsd EX-101.SCH 1914
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20220106_lab.xml EX-101.LAB 24993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20220106_pre.xml EX-101.PRE 13190
6 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20220106_htm.xml XML 11816
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 22513653
SIC: 2834 Pharmaceutical Preparations